High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles

Blood

Volumn 88, Issue 9, 1996, Pages 3456-3464

  Miyazaki, Yasuhiko ^b   Nomura, Shosaku ^a   Miyake, Tetsuya ^b   Kagawa, Hideo ^b   Kitada, Chikaho ^b   Taniguchi, Hirokazu ^b   Komiyama, Yutaka ^b   Fujimura, Yoshihiro ^b   Ikeda, Yasuo ^b   Fukuhara, Shirou ^b  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CALCIUM; CALPAIN; GLYCOPROTEIN IB; PROCOAGULANT; PROTEIN KINASE C; VON WILLEBRAND FACTOR;

ARTERY THROMBOSIS; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL OCCLUSION; CONTROLLED STUDY; EXTRACELLULAR CALCIUM; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SHEAR STRESS; THROMBOCYTE AGGREGATION; THROMBOCYTE MEMBRANE; VISCOMETER;

EID: 10344226712     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.9.3456.bloodjournal8893456     Document Type: Article

References (50)

1. Kelton JG, Warkentin TE, Hayward CPM, Murphy WG, Moore JC: Calpain activity in patients with thrombotic thrombocytopenic purpura is associated with platelet microparticles. Blood 80:2246, 1992
2. Lee YJ, Jy W, Horstman LL, Janania J, Reyes Y, Kelley RE, Ahn YS: Elevated platelet microparticles in transient ischemic attacks, lacunar infarcts, and multiinfarct dementias. Thromb Res 72:295, 1993
3. Wiedmer SE, Hall TL, Kane WH, Rosse WF, Sims PJ: Complement-induced vesiculation and exposure of membrane prothrombinase sites in platelets of paroxysmal nocturnal hemoglobinuria. Blood 82:1192, 1993
4. Jy W, Horstman LL, Arce M, Ahn YS: Clinical significance of platelet microparticles in autoimmune thrombocytopenias. J Lab Clin Med 119:334, 1991
5. George JN, Pickett EB, Sauceman S, McEver RP, Kunicki TJ, Kieffer N, Newman PJ: Platelet surface glycoproteins: Studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observations in patients during adult respiratory distress syndrome and cardiac surgery. J Clin Invest 78:340, 1986
6. Fox JEB, Austin CD, Reynolds CC, Steffen PK: Evidence that agonist-induced activation of calpain causes the shedding of procoagulant-containing microvesicles from the membrane of aggregating platelets. J Biol Chem 266:13289, 1991
7. Fox JEB, Austin CD, Boyles JK, Steffen PK: Role of membrane skeleton in preventing the shedding of procoagulant-rich microvesicles from the platelet plasma membrane. J Cell Biol 111:483, 1990
8. Zwaal RFA, Comfurius P, Bevers EM: Platelet procoagulant activity and microvesicle formation. Its putative role in hemostasis and thrombosis. Biochim Biophys Acta 1180:1, 1992
9. Sims PJ, Wiedmer T, Esmon CT, Weiss HJ, Shattil SJ: Assembly of platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. J Biol Chem 264:17049, 1989
10. Sims PJ, Faioni EM, Wiedmer T, Shattile SJ: Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J Biol Chem 263:18205, 1988
11. Wiedmer T, Shattil SJ, Cunningham M, Sims PJ: Role of calcium and calpain in complement-induced vesiculation of the platelet plasma membrane and in the exposure of the platelet factor Va receptor. Biochemistry 29:623, 1990
12. 1 integrins in platelets and platelet-derived microvesicles. Blood 82:1197, 1993
13. 2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells. Cell 80:919, 1995
14. Nomura S, Suzuki M, Kido H, Yamaguchi K, Fukuroi T, Yanabu M, Soga T, Nagata H, Kokawa T, Yasunaga K: Differences between platelet and microparticle glycoprotein IIb/IIIa. Cytometry 13:621, 1992
15. Nomura S, Nagata H, Suzuki M, Kondo K, Ohga S, Kawakatsu T, Kido H, Fukuroi T, Yamaguchi K, Iwata K, Yanabu M, Soga T, Kokawa T, Yasunaga K: Microparticle generation during in vitro activation by anti-CD9 murine monoclonal antibodies. Thromb Res 62:429, 1991
16. Ikeda Y, Handa M, Kawano K, Kamata T, Murata M, Araki Y, Anbo H, Kawai Y, Watanabe K, Itagaki I, Sakai K, Ruggeri ZM: The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress. J Clin Invest 87:1234, 1991
17. Ikeda Y, Handa M, Kamata T, Kawana K, Kamai Y, Watanabe K, Kawakami K, Sakai K, Fukuyama M, Itagaki I, Yoshioka A, Ruggeri ZM: Transmembrane calcium influx associated with von Willebrand factor binding to GPIb in the initiation of shear-induced platelet aggregation. Thromb Haemost 69:496, 1993
18. Ruggeri ZM: Mechanisms of shear-induced platelet adhesion and aggregation. Thromb Haemost 70:119, 1993
19. Moake JL, Turner NA, Stathopoulos NA, Nolasco LH, Hellums JD: Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation. J Clin Invest 78:1456, 1986
20. Moake JL, Turner NA, Stathopoulos NA, Nolasco LH, Hellums JD: Shear-induced platelet aggregation can be mediated by vWF released from platelets, as well as by exogenous large or unusually large vWF multimers, requires adenosine diphosphate, and is resistant to aspirin. Blood 58:678, 1981
21. O'Brien JR: Shear-induced platelet aggregation. Lancet 335:711, 1990
22. Butler J: Shear stress platelet activation. Lancet 346:841, 1995
23. Kroll MH, Hellums JD, Guo Z, Durante W, Razdan K, Hrbolich JK, Schafer AI: Protein kinase C is activated in platelets subjected to pathological shear stress. J Biol Chem 268:3520, 1993
24. Razdan K, Hellums JD, Kroll MH: Shear-stress-induced von Willebrand factor binding to platelets causes the activation of tyrosine kinase(s). Biochem J 302:681, 1994
25. Oda A, Yokoyama K, Murata M, Tokuhira M, Nakamura K, Hanada M, Watanabe K, Ikeda Y: Protein tyrosine phosphorylation in human platelets during shear stress-induced platelet aggregation (SIPA) is regulated by glycoprotein (GP) Ib/IX as well as GP IIb/IIIa and requires intact cytoskeleton and endogenous ADP. Thromb Haemost 74:736, 1995
26. Tsujinaka T, Kajiwara Y, Kambayashi J, Sakaon M, Higuchi N, Tanaka T, Mori T: Synthesis of a new cell penetrating calpain inhibitor (calpeptin). Biochem Biophys Res Commun 153:1201, 1988
27. Fujimura Y, Titani K, Holland LZ, Russel SR, Roberts JR, Elder JH, Ruggeri ZM, Zimmerman TS: von Willebrand factor: A reduced and alkylated 52/48 kDa fragment beginning at amino acid residue 449 contains the domain interacting with platelet glycoprotein Ib. J Biol Chem 261:381, 1986
28. Fujimura Y, Titani K, Usami Y, Suzuki M, Oyama R, Matsui T, Fukui H, Sugimoto M, Ruggeri ZM: Isolation and chemical characterization of two structurally and functionally distinct forms of botrocetin, the platelet coagglutinin isolated from the venom of Bothrops jararaca. Biochemistry 30:1957, 1991
29. Aakhus AM, Wilkinson JM, Solum NO: Binding of human platelet glycoprotein Ib and actin to fragments of actin binding protein. Thromb Haemost 67:252, 1992
30. Fujimura Y, Usami Y, Titani K, Niinomi K, Nishio K, Takase T, Yoshioka A, Fukui H: Studies on anti-von Willebrand factor (vWF) monoclonal antibody NMC-4, which inhibits both ristocetin-and botrocetin-induced vWF binding to platelet glycoprotein Ib. Blood 77:113, 1991
31. Nomura S, Nagata H, Oda K, Kokawa T, Yasunaga K: Effects of EDTA on membrane glycoprotein IIb-IIIa complex: Analysis using flow cytometry. Thromb Res 47:47, 1987
32. Yanabu M, Nomura S, Fukuroi T, Suzuki M, Kawakatsu T, Kido H, Yamaguchi K, Kokawa T, Yasunaga K: Platelet activation induced by an antiplatelet autoantibody against CD9 antigen and its inhibition by another autoantibody in immune thrombocytopenic purpura. Br J Haematol 84:694, 1993
33. Nomura S, Nagata H, Sone N, Oda K, Kokawa T, Yasunaga K: Analysis of platelet antigen for anti-platelet antibodies in idiopathic thrombocytopenic purpura using flow cytometry. Acta Haematol Jpn 51:118, 1988
34. Hamamoto K, Nomura S, Suzuki M, Ohga S, Fukuhara S: Internalization of an anti-glycoprotein IIb/IIIa antibody by HEL cells. Thromb Haemost 73:291, 1995
35. Murata M, Fukuyama M, Satoh K, Fujimura Y, Yoshida A, Takahashi H, Handa M, Kawai Y, Watanabe K, Ikeda Y: Low shear stress can initiate von Willebrand factor-dependent platelet aggregation in patients with type IIb and platelet-type von Willebrand disease. J Clin Invest 92:1555, 1993
36. Dachary-Prigent J, Freyssinet JM, Pasquet JM, Carron JC, Nurden AT: Annexin V as a probe of aminophospholipid exposure and platelet membrane vesiculation: A flow cytometry study showing a role for free sulfhydryl groups. Blood 81:2554, 1993
37. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680, 1970
38. Thiagarajan P, Tait JF: Collagen-induced exposure of anionic phospholipid in platelets and platelet-derived microparticles. J Biol Chem 266:24302, 1991
39. Kawamato S, Hidaka H: l-(5-isoquinolinesulfonyl)-2-methyl-piperazine (H-7) is a selective inhibitor of protein kinase C in rabbit platelets. Biochem Biophys Res Commun 125:258, 1984
40. Goto S, Ikeda Y, Murata M, Handa M, Takahashi E, Yoshioka A, Fujimura Y, Fukuyama M, Handa S, Ogawa S: Epinephrine augments von Willebrand factor-dependent shear-induced platelet aggregation. Circulation 86:1859, 1992
41. Fox JEB, Reynolds CC, Austin CD: The role of calpain in stimulus-response coupling: Evidence that calpain mediates agonist-induced expression of procoagulant activity in platelets. Blood 76:2510, 1990
42. Verhallen PFJ, Bevers EM, Comfurius P, Zwaal RFA: Correlation between calpain-mediated cytoskeletal degradation and expression of platelet procoagulant activity. A role for the platelet membrane skeleton in the regulation of membrane lipid asymmetry? Biochim Biophys Acta 903:206, 1987
43. Satoh K, Kawai Y, Sakai K, Watanabe K, Murata M, Handa M, Ikeda Y: Enhancement of platelet procoagulant activity by high shear stress. Blood 82:368a, 1993
44. Holme PA, Solum NO Brosstad F, Roger M, Abdelnoor M: Demonstration of platelet-derived microvesicles in blood from patients with activated coagulation and fibrinolysis using a filtration technique and western blotting. Thromb Haemost 72:666, 1994
45. Abrams CS, Ellison N, Budzynski AZ, Shattil SJ: Direct detection of activated platelets and platelet-derived microparticles in humans. Blood 75:128, 1990
46. Goto S, Salpmpn DR, Ikeda Y, Ruggeri ZM: Characterization of the unique mechanism mediating the shear-dependent binding of soluble von Willebrand factor to platelets. J Biol Chem 270:23352, 1995
47. Alkon DL, Rasmussen H: A spatial-temporal model of cell activation. Science 239:998, 1988
48. Kroll MH, Harris TS, Moake JL, Handin RI, Schafer AI: von Willebrand factor binding to platelet GP Ib initiates signals for platelet activation. J Clin Invest 88:1568, 1991
49. Saitho M, Salzman EW, Smith M, Ware JA: Activation of protein kinase C by epinephrine and A23187: Correlation with fibrinogen binding. Blood 74:2001, 1989
50. Fox JEB, Taylor RG, Taffarel M, Boyles JK, Goll DE: Evidence that activation of platelet calpain is induced as a consequence of binding of adhesive ligand to the integrin, glycoprotein IIb-IIIa. J Cell Biol 120:1501, 1993